The latest studies inserted

Kusajili is updated regularly with data from the following sources: ACTRN, EU Clinical Trials Register, GlaxoSmithKline (GSK) Clinical Study Register, Clinical Trials Search Portal provides, ISRCTN, JPRN, ClinicalTrials - NCT, Pfizer, Takeda, Pubmed.

Spotlight on 3 studies

Regularly we prefer 3 studies to help the inclusion of patients.

Phase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer

Phase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer After Failure of Platinum-Based Regimen or Anti-PD-1/ PD-L1 Based Immunotherapy

More information

Étude CA209-039 : étude de phase 1-2 évaluant la tolérance et la sécurité du nivolumab associé à du daratumumab par rapport à du daratumumab en monothérapie chez des patients ayant un myélome multiple récidivant ou réfractaire.

Deuxième cancer du sang le plus fréquent après la leucémie, le myélome se caractérise par la prolifération dans la moelle osseuse de plasmocytes, des globules blancs sécrétant des anticorps (ou immunoglobulines) mais dont la présence en excès entraîne une diminution des autres anticorps, en raison de l’étouffement de leurs cellules productrices dans la moelle, ainsi qu’une fragilisation du squelet...

More information

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

A Randomized, Double-Blind, Phase III Study of Pembrolizumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy for the Treatment of High-Risk Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (KEYNOTE-756)

More information

KUSAJILI ?

Kusajili is a protean search engine that addresses the need to simplify access to registers and patient inclusions.
Kusajili makes it possible to find in a few clicks, the numerous French and international trials referenced.
Kusajili, associated with MyHomeDoctor, facilitates multicenter clinical trials.
Docteur CRETON, Créateur de KUSAJILI

More information